A detailed history of Mercer Global Advisors Inc transactions in Twist Bioscience Corp stock. As of the latest transaction made, Mercer Global Advisors Inc holds 28,899 shares of TWST stock, worth $1.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,899
Previous 25,147 14.92%
Holding current value
$1.25 Million
Previous $863,000 65.01%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$27.95 - $53.0 $104,868 - $198,856
3,752 Added 14.92%
28,899 $1.42 Million
Q1 2024

May 15, 2024

SELL
$32.28 - $41.5 $28,148 - $36,188
-872 Reduced 3.35%
25,147 $863,000
Q4 2023

Feb 14, 2024

BUY
$15.08 - $38.61 $56,082 - $143,590
3,719 Added 16.68%
26,019 $959,000
Q3 2023

Nov 13, 2023

BUY
$18.62 - $26.57 $217,016 - $309,673
11,655 Added 109.49%
22,300 $452,000
Q2 2023

Aug 14, 2023

BUY
$11.49 - $20.46 $122,311 - $217,796
10,645 New
10,645 $217,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.44B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.